Myomo (MYO) Amortizatization of Intangibles (2016 - 2025)
Myomo (MYO) posted Amortizatization of Intangibles of $187779.0 for Q3 2025, down 20.98% on a QoQ basis from $237649.0 in Q2 2025, and up 1872.26% year-over-year from $9521.0 in Q3 2024.
Myomo (MYO) Amortizatization of Intangibles (2016 - 2025) Analysis & Trends
Myomo's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $187779.0 for Q3 2025.
- Quarterly Amortizatization of Intangibles rose 1872.26% year-over-year to $187779.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $714457.0 (up 51.4% YoY) and the FY2024 annual result came in at $118598.0, down 66.44% from the prior year.
- Amortizatization of Intangibles was $187779.0 for Q3 2025 at Myomo, down from $237649.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $353375.0 in Q4 2023 and bottomed at -$253611.0 in Q4 2022.
- A 5-year average of $76462.2 and a median of $61692.5 in 2021 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 499.77% — and 2025, when it soared 1872.26%.
- Myomo's Amortizatization of Intangibles stood at $63439.0 in 2021, then slumped by 499.77% to -$253611.0 in 2022, then soared by 239.34% to $353375.0 in 2023, then slumped by 99.98% to $78.0 in 2024, then soared by 240642.31% to $187779.0 in 2025.
- Business Quant data shows MYO's Amortizatization of Intangibles at $187779.0 in Q3 2025, $237649.0 in Q2 2025, and $288951.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 187,779.00 |
| Sep 30, 2025 | 187,779.00 |
| Jun 30, 2025 | 237,649.00 |
| Jun 30, 2025 | 237,649.00 |
| Mar 31, 2025 | 288,951.00 |
| Mar 31, 2025 | 288,951.00 |
| Dec 31, 2024 | 78.00 |
| Dec 31, 2024 | 78.00 |
| Sep 30, 2024 | 9,521.00 |
| Sep 30, 2024 | 9,521.00 |
| Jun 30, 2024 | 59,946.00 |
| Jun 30, 2024 | 59,946.00 |
| Mar 31, 2024 | 49,053.00 |
| Mar 31, 2024 | 49,053.00 |
| Dec 31, 2023 | 353,375.00 |
| Dec 31, 2023 | 353,375.00 |
| Jun 30, 2023 | -101,829.00 |
| Jun 30, 2023 | -101,829.00 |
| Mar 31, 2023 | 101,829.00 |
| Mar 31, 2023 | 101,829.00 |